| Literature DB >> 34102403 |
Reyhaneh Zafarnejad1, Paul M Griffin2.
Abstract
Many schools and universities have seen a significant increase in the spread of COVID-19. As such, a number of non-pharmaceutical interventions have been proposed including distancing requirements, surveillance testing, and updating ventilation systems. Unfortunately, there is limited guidance for which policy or set of policies are most effective for a specific school system. We develop a novel approach to model the spread of SARS-CoV-2 quanta in a closed classroom environment that extends traditional transmission models that assume uniform mixing through air recirculation by including the local spread of quanta from a contagious source. In addition, the behavior of students with respect to guideline compliance was modeled through an agent-based simulation. Estimated infection rates were on average lower using traditional transmission models compared to our approach. Further, we found that although ventilation changes were effective at reducing mean transmission risk, it had much less impact than distancing practices. Duration of the class was an important factor in determining the transmission risk. For the same total number of semester hours for a class, delivering lectures more frequently for shorter durations was preferable to less frequently with longer durations. Finally, as expected, as the contact tracing level increased, more infectious students were identified and removed from the environment and the spread slowed, though there were diminishing returns. These findings can help provide guidance as to which school-based policies would be most effective at reducing risk and can be used in a cost/comparative effectiveness estimation study given local costs and constraints.Entities:
Keywords: Agent-based simulation; Contact tracing; SARS-CoV-2 (COVID-19); Social distancing; Surveillance testing; Ventilation; Virus airborne transmission
Year: 2021 PMID: 34102403 PMCID: PMC8163694 DOI: 10.1016/j.compbiomed.2021.104518
Source DB: PubMed Journal: Comput Biol Med ISSN: 0010-4825 Impact factor: 4.589
Fig. 1A schematic diagram of the role for agent-based simulations on clinical and experimental trial design and policy assessment.
Fig. 2A schematic view of sample quanta-cone with the height of 2.5 m and diameter of 1.2 m, derived using Monte Carlo simulation.
Fig. 3The classroom scheme and the estimated risk map for a 49-seat classroom. Students sitting in front of infectious agents have higher risk of infection. The risk of infection is assumed to be zero for already infected agents and empty cells.
Model parameters summary.
| Parameter | Value/Range | Reference | Description | |
|---|---|---|---|---|
| Propagation ratios | Prevalence rate | 0.017 | [ | Latest prevalence rate of COVID-19 |
| Asymptomatic ratio | 0.40 | [ | Among all the infected population | |
| Pre symptomatic ratio | 0.60 | [ | Among all the infected population | |
| Mildly symptomatic ratio | 0.81 | [ | Among all the pre-symptomatic population | |
| Severely symptomatic ratio | 0.19 | [ | Among all the pre-symptomatic population | |
| Fertility rate | 0.023 | [ | – | |
| Behavioral factors | Adherence to rules factor | 0.88 (female), 0.83 (male) | [ | Different among males and females |
| Stress level impact | 0.6 | Assumed, [ | Stress and increase adherence to rules by 60% | |
| Resilience impact | 0.46 | [ | Resilience can reduce stress by 46% | |
| Disease characteristics | Incubation period | Normal (μ = 5.75, σ = 5.75/3)* (days) | [ | The period between exposure and the onset of symptoms |
| Latent period | Normal (μ = 2, σ = 2/3)* | [ | The period between exposure and the onset of the period of communicability | |
| Recovery period | 14 (days) | [ | The period between symptoms onset and recovery (end of preciousness and isolation) | |
| Transmission model parameters | D | 1.83 (m) | Assumed | Distance between agents |
| ERq | 120*0.30 (quanta h−1) | [ | Quanta emission rate with two-layer cotton mask | |
| IVRR | 0.87–2.2 (h−1) | [ | Infectious virus removal rate | |
| IR | 0.9 (h−1) | [ | Inhalation rate | |
| Class duration | 150, 75, 75*, 50 (mins) | Assumed | * Two types of schedule | |
| Number of sessions per week | 1, 2, 2*, 3 | Assumed | * Two types of schedule | |
| Testing parameters | Surveillance testing sample size | 0.10 | Assumed [ | Sample size varies by University, from 1% to 100% of the population |
| Test accuracy | 90% | [ | Test accuracy ranges from 84.0% to 97.6% depending on the type of test. | |
| Test results delay | 2 (days) | Assumed | – | |
| Contact tracing level | 0.00, 0.25, 0.50, 0.75, 1.00 | Assumed | The percentage of all contacts that can be traced |
Fig. 4Transmission risk among students – traditional and novel risk models: the orange curve shows the traditional transmission risk as a function of time. The purple curves show different possible transmission risks based on a class with randomly seated students. The closer a susceptible agent is to an infectious one, the higher the risk of transmission.
Fig. 5Transmission risks under different number of sessions per week; (2–5) and (3–4) indicate two days a week schedule with 2,5/3,4 days in between sessions.
Pairwise statistical significance, mean estimated risk for different testing types and class schedules (E.g. (2–5) indicates twice a week class, with 2 days and 5 days in between sessions each week.)
| Test type | Comparison between | Decrease in relative estimated risk (%) | P-Value |
|---|---|---|---|
| No Testing | 1 & (2–5) | −22.92859307 | 7.78E-34 |
| No Testing | 1 & (3–4) | −22.38583209 | 5.07E-28 |
| No Testing | 1 & 3 | −36.43440135 | 3.18E-59 |
| No Testing | (2–5) & (3–4) | 0.704231305 | 0.57267465 |
| No Testing | (2–5) & 3 | −17.52375987 | 3.40E-61 |
| No Testing | (3–4) & 3 | −18.10052164 | 2.19E-33 |
| Testing without contact tracing | 1 & (2–5) | −26.21191343 | 4.85E-95 |
| Testing without contact tracing | 1 & (3–4) | −27.60694191 | 9.15E-69 |
| Testing without contact tracing | 1 & 3 | −40.50588898 | 4.00E-105 |
| Testing without contact tracing | (2–5) & (3–4) | −1.890587684 | 0.150827744 |
| Testing without contact tracing | (2–5) & 3 | −19.3716577 | 1.11E-39 |
| Testing without contact tracing | (3–4) & 3 | −17.81793367 | 4.85E-23 |
| Contact tracing level = 25% | 1 & (2–5) | −33.04294744 | 1.36E-35 |
| Contact tracing level = 25% | 1 & (3–4) | −35.47258901 | 1.69E-35 |
| Contact tracing level = 25% | 1 & 3 | −42.88151741 | 3.36E-51 |
| Contact tracing level = 25% | (2–5) & (3–4) | −3.628656699 | 0.232224364 |
| Contact tracing level = 25% | (2–5) & 3 | −14.69385165 | 6.97E-08 |
| Contact tracing level = 25% | (3–4) & 3 | −11.48183119 | 1.95E-04 |
| Contact tracing level = 50% | 1 & (2–5) | −36.33525192 | 1.05E-19 |
| Contact tracing level = 50% | 1 & (3–4) | −29.83105901 | 1.16E-14 |
| Contact tracing level = 50% | 1 & 3 | −35.21480929 | 1.79E-21 |
| Contact tracing level = 50% | (2–5) & (3–4) | 10.21631767 | 0.040307504 |
| Contact tracing level = 50% | (2–5) & 3 | 1.759910564 | 0.691255565 |
| Contact tracing level = 50% | (3–4) & 3 | −7.672554559 | 0.055895315 |
| Contact tracing level = 75% | 1 & (2–5) | −30.85989953 | 2.62914E-07 |
| Contact tracing level = 75% | 1 & (3–4) | −36.36859778 | 3.7326E-10 |
| Contact tracing level = 75% | 1 & 3 | −32.63912962 | 3.76965E-09 |
| Contact tracing level = 75% | (2–5) & (3–4) | −7.967443237 | 0.266966906 |
| Contact tracing level = 75% | (2–5) & 3 | −2.573369264 | 0.70534712 |
| Contact tracing level = 75% | (3–4) & 3 | 5.861049787 | 0.392950847 |
| Contact tracing level = 100% | 1 & (2–5) | −31.9272862 | 7.30E-05 |
| Contact tracing level = 100% | 1 & (3–4) | −39.96963412 | 3.62E-08 |
| Contact tracing level = 100% | 1 & 3 | −41.44829553 | 2.81227E-08 |
| Contact tracing level = 100% | (2–5) & (3–4) | −11.81434892 | 0.217198567 |
| Contact tracing level = 100% | (2–5) & 3 | −13.98652823 | 0.157257011 |
| Contact tracing level = 100% | (3–4) & 3 | −2.463189057 | 0.792342997 |
Fig. 6The impact of distance and ventilation on the mean transmission risk in a 3- days a week class with no testing or contact tracing within 100 replications of the model.
Fig. 7Epidemic size: the average number of agents experiencing each possible health status per day, for 100 replications. As more controlling policies are put into action, the epidemic size reduces.
Key findings and associated implications regarding policy assessment – only significant changes are reported here.
| Policy | Range of Effectiveness (reduction in the relative mean transmission risk %) | Requirements for Implementation | Speed of Implementation | Source(s) |
|---|---|---|---|---|
| Campus facilities including larger classrooms and labs - human resources and faculty members - virtual tools for distance learning | Rapid | [ | ||
| > | Similar to social distancing | Rapid | Assumption | |
| > | Financial resources, safety challenges | Slow | [ | |
| > | Ethical, legal, security and privacy requirements | Slow | [ |